相似文献
1
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.
Br J Cancer. 2003 Sep 15;89(6):1028-30. doi: 10.1038/sj.bjc.6601242.
2
Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Asia Pac J Clin Oncol. 2015 Dec;11(4):e22-30. doi: 10.1111/ajco.12091. Epub 2014 May 30.
3
Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
Surg Oncol. 2018 Mar;27(1):88-94. doi: 10.1016/j.suronc.2018.01.002. Epub 2018 Jan 9.
4
Biomarkers in the lung cancer diagnosis: a clinical perspective.
Neoplasma. 2012;59(5):500-7. doi: 10.4149/neo_2012_064.
5
Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking.
Asian Pac J Cancer Prev. 2013;14(8):4819-22. doi: 10.7314/apjcp.2013.14.8.4819.
6
Serum chemokine network correlates with chemotherapy in non-small cell lung cancer.
Cancer Lett. 2015 Aug 28;365(1):57-67. doi: 10.1016/j.canlet.2015.05.001. Epub 2015 May 11.
7
Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Clin Lung Cancer. 2017 Mar;18(2):e99-e107. doi: 10.1016/j.cllc.2016.09.012. Epub 2016 Oct 5.
8
Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Asian Pac J Cancer Prev. 2015;16(4):1421-5. doi: 10.7314/apjcp.2015.16.4.1421.
9
Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study.
Sci Rep. 2019 May 31;9(1):8143. doi: 10.1038/s41598-019-44653-x.
10
Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Asian Pac J Cancer Prev. 2015;16(12):4891-4. doi: 10.7314/apjcp.2015.16.12.4891.
引用本文的文献
1
Development of a predictive score for prolonged pelvic operation time in robot-assisted low anterior resection: a single-center, retrospective study in Japan.
Surg Endosc. 2025 Sep 8. doi: 10.1007/s00464-025-12122-4.
2
Comparative Prognostic Accuracy of Clinical and Inflammation- or Nutrition-Based Scores in Older Adults with Community-Acquired Pneumonia.
Int J Gen Med. 2025 Aug 27;18:4811-4824. doi: 10.2147/IJGM.S540730. eCollection 2025.
3
The role of the modified Glasgow prognostic score in predicting postoperative mortality following open-heart surgery.
J Cardiothorac Surg. 2025 Jul 25;20(1):310. doi: 10.1186/s13019-025-03503-w.
4
Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: an observational study.
Gastric Cancer. 2025 Jul 8. doi: 10.1007/s10120-025-01637-3.
5
Preoperative systemic inflammatory biomarkers can improve recurrence prediction of non-muscle invasive bladder cancer after endoscopic resection - a prospective observational study.
Contemp Oncol (Pozn). 2025;29(2):188-194. doi: 10.5114/wo.2025.151064. Epub 2025 May 13.
6
Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases.
Ann Gastroenterol Surg. 2025 Jan 24;9(4):750-760. doi: 10.1002/ags3.12918. eCollection 2025 Jul.
7
MRI radiomics model for predicting tumor immune microenvironment types and efficacy of anti-PD-1/PD-L1 therapy in hepatocellular carcinoma.
BMC Med Imaging. 2025 Jul 1;25(1):211. doi: 10.1186/s12880-025-01751-9.
8
Predictive factors and nomogram for the risk of cytokine release syndrome with anti-CD3 × CD20 bispecific antibodies for Chinese patients.
Cancer Immunol Immunother. 2025 Jun 4;74(7):236. doi: 10.1007/s00262-025-04080-6.
9
Prognostic value of the pretreatment Glasgow prognostic score or modified Glasgow prognostic score in patients with advanced cancer receiving immune checkpoint inhibitors: A systematic review and meta‑analysis.
Oncol Lett. 2025 May 2;30(1):323. doi: 10.3892/ol.2025.15069. eCollection 2025 Jul.
10
Surgical Outcomes of Minimally Invasive Lung Resection in Nonagenarians: A Retrospective Analysis of Seven Patients at a Single Institution.
Cureus. 2025 Apr 13;17(4):e82186. doi: 10.7759/cureus.82186. eCollection 2025 Apr.
本文引用的文献
1
A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer.
Lung Cancer. 2003 Jun;40(3):295-9. doi: 10.1016/s0169-5002(03)00077-1.
2
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.
Br J Cancer. 2002 Jul 29;87(3):264-7. doi: 10.1038/sj.bjc.6600466.
3
The role of C-reactive protein as a prognostic indicator in advanced cancer.
Curr Oncol Rep. 2002 May;4(3):250-5. doi: 10.1007/s11912-002-0023-1.
4
Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer.
Br J Cancer. 2001 Nov 30;85(11):1634-9. doi: 10.1054/bjoc.2001.2162.
5
Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
Lung Cancer. 2001 Jun;32(3):213-26. doi: 10.1016/s0169-5002(00)00222-1.
6
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
Nutr Cancer. 2000;37(1):36-40. doi: 10.1207/S15327914NC3701_4.
7
8
Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer.
Cytokine. 1999 Jan;11(1):80-6. doi: 10.1006/cyto.1998.0398.
9
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
Cancer. 1999 Jan 15;85(2):333-40. doi: 10.1002/(sici)1097-0142(19990115)85:2<333::aid-cncr10>3.0.co;2-q.
10
Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients.
Nutr Cancer. 1998;31(2):101-5. doi: 10.1080/01635589809514687.
Zotero 插件